Arcellx, Inc. (ACLX)
67.55
-1.25
(-1.82%)
USD |
NASDAQ |
Feb 10, 10:29
Arcellx Market Cap : 3.906B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 186.88B |
| Johnson & Johnson | 574.09B |
| Amicus Therapeutics, Inc. | 4.414B |
| Relmada Therapeutics, Inc. | 304.33M |
| Invivyd, Inc. | 348.52M |
Market Cap Related Metrics
| PS Ratio | 104.60 |
| PEG Ratio | -0.0405 |
| Price to Book Value | 8.862 |
| Price | 67.55 |
| Earnings Yield | -5.80% |
| PEGY Ratio | -0.0405 |